Ostrowski Erik

Ostrowski Erik is listed in filings as SVP at Akebia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Akebia Therapeutics, Inc. (AKBA). The current snapshot covers public activity from Jul 2, 2024 to Feb 4, 2026. Reported amounts are shown as $48.6K to $151.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.